Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Cost savings and enhanced hospice enrollment with a home-based palliative care program implemented as a hospice-private payer partnership.

Kerr CW, Donohue KA, Tangeman JC, Serehali AM, Knodel SM, Grant PC, Luczkiewicz DL, Mylotte K, Marien MJ.

J Palliat Med. 2014 Dec;17(12):1328-35. doi: 10.1089/jpm.2014.0184.

PMID:
25375799
2.

Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.

Woods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M, Horan J, Appelbaum FR, Estey EH, Bloomfield CD, Larson RA.

Cancer. 2013 Dec 1;119(23):4170-9. doi: 10.1002/cncr.28344. Epub 2013 Sep 19.

3.

Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.

Lin TS, Donohue KA, Byrd JC, Lucas MS, Hoke EE, Bengtson EM, Rai KR, Atkins JN, Link BK, Larson RA.

J Clin Oncol. 2010 Oct 10;28(29):4500-6. doi: 10.1200/JCO.2010.29.7978. Epub 2010 Aug 9.

4.

Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804.

Katz ML, Donohue KA, Alfano CM, Day JM, Herndon JE 2nd, Paskett ED.

Cancer. 2009 Feb 1;115(3):480-8. doi: 10.1002/cncr.24063.

5.

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.

Stone RM, Donohue KA, Stock W, Hars V, Linker CA, Shea T, Deangelo DJ, Marcucci G, Bloomfield CD, Larson RA; Cancer and Leukemia Group B.

Cancer Chemother Pharmacol. 2009 Apr;63(5):859-64. doi: 10.1007/s00280-008-0805-8. Epub 2008 Aug 1.

PMID:
18670778
6.

Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.

Wetzler M, Donohue KA, Odenike OM, Feldman EJ, Hurd DD, Stone RM, Westerfelt P, Bloomfield CD, Larson RA.

Leuk Lymphoma. 2008 Jul;49(7):1274-8. doi: 10.1080/10428190802043887.

7.

Long-term outcome of stage I seminoma.

Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR.

Am J Clin Oncol. 2007 Apr;30(2):205-10.

PMID:
17414472
8.

Misrepresentation of publications among radiation oncology residency applicants.

Yang GY, Schoenwetter MF, Wagner TD, Donohue KA, Kuettel MR.

J Am Coll Radiol. 2006 Apr;3(4):259-64.

PMID:
17412057
9.

Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.

Wetzler M, Brady MT, Tracy E, Li ZR, Donohue KA, O'Loughlin KL, Cheng Y, Mortazavi A, McDonald AA, Kunapuli P, Wallace PK, Baer MR, Cowell JK, Baumann H.

Clin Cancer Res. 2006 Nov 15;12(22):6817-25.

10.

Management of locoregional stage esophageal cancer: a single center experience.

Javle MM, Nwogu CE, Donohue KA, Iyer RV, Brady WE, Khemka SV, Smith JL, Demmy TL, Yang GY, Nava HR.

Dis Esophagus. 2006;19(2):78-83.

PMID:
16643174
11.

T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.

Claus JA, Brady MT, Lee J, Donohue KA, Sait SN, Ferrone S, Wetzler M.

Cancer Immunol Immunother. 2006 Feb;55(2):160-5. Epub 2005 Jul 12.

PMID:
16010586
12.

Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR, Baumann H, Wetzler M.

Blood. 2002 Jan 1;99(1):252-7.

PMID:
11756179
13.

Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.

Xia Z, Sait SN, Baer MR, Barcos M, Donohue KA, Lawrence D, Ford LA, Block AM, Baumann H, Wetzler M.

Leuk Res. 2001 Jun;25(6):473-82.

PMID:
11337019
14.

The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.

Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB.

Gynecol Oncol. 2000 Aug;78(2):137-42.

PMID:
10926792

Supplemental Content

Loading ...
Support Center